BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11838417)

  • 1. [The myelodysplastic syndrome I. Pathogenesis, clinical symptoms, diagnosis and differential diagnosis].
    Hasselbalch HC; Juhl BR; Hansen PB
    Ugeskr Laeger; 2002 Jan; 164(4):476-9. PubMed ID: 11838417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, classification, and course of myelodysplastic syndromes.
    McKenna RW; Allison PM
    Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelodysplastic syndromes].
    Garandeau C; Pautas E; Andreux M; Andreux J; Gaussem P; Siguret V
    Ann Biol Clin (Paris); 2000; 58(4):405-16. PubMed ID: 10932040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myelodysplastic syndromes.
    Masey JA
    Br J Biomed Sci; 1997 Mar; 54(1):65-70. PubMed ID: 9167309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndromes or refractory anemias].
    Fenaux P
    Rev Prat; 1993 Jun; 43(11):1379-85. PubMed ID: 8235387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The myelodysplastic syndrome: the problems of its pathogenesis and treatment].
    Savchenko VG; Parovichnikova EN; Mikhaĭlova EA; Ol'shanskaia IuV; Ustinova EN; Gribanova EO; Frank GA; Tikhonova LIu; Kokhno AV; Obidina NA; Kuchma IuM
    Ter Arkh; 1996; 68(7):31-7. PubMed ID: 8928069
    [No Abstract]   [Full Text] [Related]  

  • 9. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematological changes associated with human immunodeficiency virus (HIV-1) infection].
    Møller T; Hasselbalch HC
    Ugeskr Laeger; 1993 May; 155(19):1442-6. PubMed ID: 8316970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathobiology, classification, and diagnosis of myelodysplastic syndrome.
    Mufti GJ
    Best Pract Res Clin Haematol; 2004 Dec; 17(4):543-57. PubMed ID: 15494293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.
    Valent P; Horny HP
    Eur J Clin Invest; 2009 Jul; 39(7):548-53. PubMed ID: 19453651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
    Varma N; Varma S; Marwaha N; Garewal G
    Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.
    Aggarwal S; van de Loosdrecht AA; Alhan C; Ossenkoppele GJ; Westers TM; Bontkes HJ
    Br J Haematol; 2011 Jun; 153(5):568-81. PubMed ID: 21488861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
    Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
    Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
    Niemeyer CM; Kratz CP
    Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
    Panani AD; Roussos C
    Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.